JP2017530193A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530193A5
JP2017530193A5 JP2017535616A JP2017535616A JP2017530193A5 JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5 JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
heterocycloalkyl
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017535616A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017530193A (ja
JP6615207B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/051143 external-priority patent/WO2016048861A2/en
Publication of JP2017530193A publication Critical patent/JP2017530193A/ja
Publication of JP2017530193A5 publication Critical patent/JP2017530193A5/ja
Application granted granted Critical
Publication of JP6615207B2 publication Critical patent/JP6615207B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017535616A 2014-09-22 2015-09-21 複素環式化合物及びその使用 Active JP6615207B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462053389P 2014-09-22 2014-09-22
US62/053,389 2014-09-22
PCT/US2015/051143 WO2016048861A2 (en) 2014-09-22 2015-09-21 Heterocyclic compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2017530193A JP2017530193A (ja) 2017-10-12
JP2017530193A5 true JP2017530193A5 (https=) 2018-11-01
JP6615207B2 JP6615207B2 (ja) 2019-12-04

Family

ID=55525127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017535616A Active JP6615207B2 (ja) 2014-09-22 2015-09-21 複素環式化合物及びその使用

Country Status (12)

Country Link
US (2) US9862703B2 (https=)
EP (1) EP3197885B1 (https=)
JP (1) JP6615207B2 (https=)
KR (1) KR102509431B1 (https=)
CN (1) CN107207465B (https=)
AU (1) AU2015321654B2 (https=)
BR (1) BR112017005713B1 (https=)
CA (1) CA2962329C (https=)
ES (1) ES2849998T3 (https=)
RU (1) RU2704008C2 (https=)
TW (1) TWI598348B (https=)
WO (1) WO2016048861A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6982716B2 (ja) * 2017-01-10 2021-12-17 ナショナル ヘルス リサーチ インスティチューツ 複素環式化合物及びその使用
IL302338B2 (en) * 2017-09-08 2024-10-01 Univ Leland Stanford Junior Enpp1 inhibitors and their use for the treatment of cancer
WO2020060268A1 (ko) 2018-09-20 2020-03-26 한미약품 주식회사 상피세포 성장인자 수용체 돌연변이 저해 효과를 갖는 신규 융합 피리미딘 골격 설폰아마이드 유도체
MX2021009269A (es) * 2019-02-01 2021-08-24 Univ Leland Stanford Junior Inhibidores de enpp1 y metodos para modular una respuesta inmunitaria.
CN111138417B (zh) * 2019-12-18 2021-03-23 浙江工业大学 一种三氮唑修饰的5-氟-2,4-嘧啶二胺类化合物及其应用
WO2023014611A1 (en) * 2021-08-02 2023-02-09 Yeh, Teng-Kuang Pyrimidine compounds and use thereof
WO2024101337A1 (ja) * 2022-11-07 2024-05-16 国立大学法人京都大学 キナゾリン誘導体
TW202435887A (zh) 2023-03-01 2024-09-16 瑞士商諾華公司 用於治療疾病或障礙的氫喹唑啉衍生物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4936700A (https=) * 1972-08-16 1974-04-05
FI944602A0 (fi) * 1992-04-03 1994-10-03 Upjohn Co Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
EP2043651A2 (en) 2006-07-05 2009-04-08 Exelixis, Inc. Methods of using igf1r and abl kinase modulators
AU2009228034A1 (en) * 2008-03-28 2009-10-01 Altiris Therapeutics Chemokine receptor modulators
CN102046609B (zh) 2008-03-31 2014-05-14 全药工业株式会社 具有细胞保护效果的嘧啶衍生物及其应用
AU2008355098B2 (en) 2008-04-21 2012-11-15 Gpcr Therapeutics, Inc Heterocyclic compounds
WO2010046780A2 (en) 2008-10-22 2010-04-29 Institut Pasteur Korea Anti viral compounds
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
KR20140069235A (ko) 2011-09-27 2014-06-09 노파르티스 아게 돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
CN104379180A (zh) 2012-04-10 2015-02-25 佐治亚州立大学研究基金会公司 用cyld抑制剂治疗中耳炎及其它病状的组合物和方法
LT2906563T (lt) 2012-10-10 2018-06-11 Janssen Sciences Ireland Uc Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
US20150259649A1 (en) 2012-11-08 2015-09-17 Emory University Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto

Similar Documents

Publication Publication Date Title
JP2017530193A5 (https=)
RU2017109355A (ru) Гетероциклические соединения и их применение
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
JP2021512150A5 (https=)
CY1118909T1 (el) Αμιδια οξαλικου οξεος ως αναστολεις νεπριλυσινης, φαρμακευτικη συνθεση αυτων και παρασκευη αυτων
JP2016518328A5 (https=)
JP2015522650A5 (https=)
JP2016516043A5 (https=)
JP2016053042A5 (https=)
JP2016540803A5 (https=)
AR086983A1 (es) Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
PE20190395A1 (es) Pirimidin-2-ilamino-1h-pirazoles como inhibidores de lrrk2 para el uso en el tratamiento de trastornos neurodegenerativos
AR059338A1 (es) N-fenilbenzotriazolilo como inhibidores de c-kit
JP2017509586A5 (https=)
JP2007524696A5 (https=)
RU2013109132A (ru) Химические соединения
AR064726A1 (es) Inhibidores de rho quinasa
JP2015534574A5 (https=)
JP2020500869A5 (https=)
PE20141598A1 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
JP2019529419A5 (https=)
JP2014503567A5 (https=)
AR073551A1 (es) Pirimidinas macrociclicas como inhibidores de proteina cinasa
AR067513A1 (es) Derivados de 1,2-oxazol
JP2016513696A5 (https=)